Aa. Aroutcheva et al., Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems, CLIN INF D, 33(7), 2001, pp. 1022-1027
The differences in the phenotype and genotype of Gardnerella vaginalis isol
ates from patients with bacterial vaginosis (BV) and from patients without
BV are unknown. In our study, 43 isolates of G. vaginalis were examined for
biotype (hippurate hydrolysis, lipase, and beta -galactosidase activity),
sensitivity to metronidazole, and genotype. Of the 117 women visiting the g
ynecology clinic at Rush-Presbyterian-St. Luke's Medical Center who were in
cluded in the study, 27.4% were found to have BV. G. vaginalis was found in
samples from 87.5% of women with BV, from 34.0% of women with intermediate
BV, and from 26.4% of women with healthy vaginal ecosystems. Among patient
s with G. vaginalis, biotypes 7 and 8 were isolated from 32% and 20% of pat
ients, respectively. Biotype 5 was predominantly associated with a healthy
vaginal ecosystem (P=.0004). Biotypes 5 and 7 were the most resistant to me
tronidazole. No specific phenotype or genotype of G. vaginalis causes BV.